Stock Reports

VITZROCELL Co., Ltd. Raises Earnings Forecast, but... Target Price Lowered - Samsung

KIM YOON-JEONG
2026-07-23 07:46:15
[Edaily Reporter KIM YOON-JEONG ] SamsungSecurities assessed that while VITZROCELL Co., Ltd.(082920)’s second-quarter earnings fell short of market expectations due to one-time costs, profitability in its core business is improving. The firm raised its earnings forecast for this year based on the growth momentum of the high-temperature battery business and noted that the recent stock price correction should be viewed as a buying opportunity. It maintained its “Buy” rating but lowered the target price to 43,000 won.
(Source: SamsungSecurities)

On the 23rd, Jang Jeong-hoon, an analyst at SamsungSecurities, stated, “As ceasefire negotiations for the Middle East war—one of the factors driving the first-half stock rally—began in mid-June, a stock price correction was inevitable,” adding, “We view this correction as an opportunity to buy at a favorable price and therefore maintain our ‘Buy’ recommendation.” In fact, VITZROCELL Co., Ltd.’s stock price fell by approximately 43% from June 1 to July 22.
VITZROCELL Co., Ltd.’s second-quarter revenue was 76.3 billion won, and operating profit was 19.6 billion won, both falling short of the market consensus (operating profit of 22.6 billion won). This was due to the inclusion of one-time expenses totaling approximately 4 billion won, such as employee incentives.
However, analysts assess that profitability improved compared to the previous quarter when excluding these one-time factors. Revenue from the core “Bobbin” battery division increased by 12% year-over-year, while the high-margin high-temperature battery division grew by 102%, contributing to improved profitability in the company’s core business.
SamsungSecurities also revised its full-year earnings forecast upward. It projected that this year’s revenue would reach 321.6 billion won, a 32% increase from the previous year, and operating profit would total 98 billion won, resulting in an operating profit margin (OPM) of 30.5%—the highest annual profitability on record.
Analyst Jang noted, “In the high-temperature battery segment, the impact of reflecting consolidated results from last year’s acquisition of a Canadian battery pack manufacturer, combined with the effects of fires at North American competitors this year, is expected to lead to growth and improved profitability in the second half of the year.”
The target price was set at 43,000 won, lower than the previous estimate. This reflects the fact that the average price-to-earnings (P/E) ratio of peer companies in the rechargeable battery sector has fallen from 52.6x to 40.3x.
However, the firm maintained its “Buy” rating. SamsungSecurities noted that while the potential for a new business in lithium capacitors for artificial intelligence data center (AIDC) servers remains valid, valuation pressures are expected to decrease significantly as profitability in the existing primary battery business improves, based on an estimated net cash position of 181.3 billion won in 2026.

Economy

Corporation

IT·Science

Economy

SamsungElectroMechanics Strengthens Alliance with NVIDIA on AI Semiconductor Substrates… Dedicated Factories to Be Built in Sejong and Busan

SamsungElectroMechanics is strengthening its collaboration with NVIDIA, the world’s largest artificial intelligence (AI) semiconductor company, in the field of next-generation semiconductor package su…
2026-10-21 20:40:02

Corporation

i-Scream Edu Co., Ltd. Faces Risk of Becoming First Company in Education Sector to Be Delisted… Suspicions of “Intentional Delisting” Also Arise

Edutech company i-Scream Edu Co., Ltd.(289010)is at risk of becoming the first education company to be delisted from the stock market following the government’s introduction of a delisting system rela…
2026-10-21 15:55:38

IT·Science

'Keytruda SC,' Featuring Alteogen Inc. Technology, Expands Indications for Bladder Cancer in Europe

"Keytruda SC," which incorporates subcutaneous (SC) formulation technology from Alteogen Inc.(196170), has had its indication expanded in Europe to include the treatment of muscle-invasive bladder can…
2026-10-21 21:17:02